SecProbe.io

CORRESP
1
filename1.htm

Haoxi Health Technology Limited

January 24, 2024

Via EDGAR

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Attention:
    Robert Shapiro

    Doug Jones

    Nicholas Nalbantian

    Erin Jaskot

    Re:
    Haoxi Health Technology Limited

    Registration Statement on Form F-1, as amended

    Initially Filed on August 25, 2023

    File No. 333-274214

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests
that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration
Statement become effective at 4.00 p.m., Eastern Time, on January 25, 2024, or as soon thereafter as practicable.

    Very truly yours,

    Haoxi Health Technology Limited

    By:
    /s/ Fan Zhen

    Name:
    Fan Zhen

    Title:
    Chief Executive Officer, Director